Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Price:
23.92 USD
-3.86%
Market Closed
Updated:
May 29, 2024
Arrowhead Pharmaceuticals Inc
Total Current Assets
|
Arrowhead Pharmaceuticals Inc
Total Current Assets Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
|
Total Current Assets
$541.7m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
18%
|
CAGR 10-Years
13%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Current Assets
$38.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
22%
|
CAGR 10-Years
8%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Current Assets
$14B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
1%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Current Assets
$28B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Current Assets
$13.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
26%
|
CAGR 10-Years
25%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Current Assets
$18.9B
|
CAGR 3-Years
23%
|
CAGR 5-Years
22%
|
CAGR 10-Years
26%
|
See Also
What is Arrowhead Pharmaceuticals Inc's Total Current Assets?
Total Current Assets
541.7m
USD
541.7m
USD
Based on the financial report for Mar 31, 2024, Arrowhead Pharmaceuticals Inc's Total Current Assets amounts to 541.7m USD.
What is Arrowhead Pharmaceuticals Inc's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
13%
13%
Over the last year, the Total Current Assets growth was -6%. The average annual Total Current Assets growth rates for Arrowhead Pharmaceuticals Inc have been -3% over the past three years , 18% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
